Ftse Mib
33.674,33
1,37%
DAX
18.254,18
1,03%
S&P 500
5.478,16
-0,16%
NASDAQ
17.752,05
-0,62%
Bitcoin
65.058,04
0,14%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Plus Therapeutics Inc (PSTV) Plus Therapeutics Inc (PSTV) Notizie

Plus Therapeutics Inc

PSTV
1,92
-0,01 (-0,52%)
Ultimo aggiornamento: 20:33:43
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
07/6/202423:02EDGAR2Form S-1 - General form for registration of securities under..
07/6/202422:02EDGAR2Form 8-K - Current report
07/6/202413:30GLOBEPlus Therapeutics Expands Management Team and Reports $3.3M..
05/6/202413:26EDGAR2Form SC 13G - Statement of acquisition of beneficial..
04/6/202423:16EDGAR2Form 8-K - Current report
20/5/202413:00EDGAR2Form 8-K - Current report
17/5/202423:00GLOBEPlus Therapeutics Announces New Employment Inducement Grants
15/5/202422:15GLOBEPlus Therapeutics Reports First Quarter 2024 Financial..
15/5/202422:01EDGAR2Form 8-K - Current report
15/5/202422:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202413:30GLOBEPlus Therapeutics to Announce First Quarter Financial..
10/5/202413:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202413:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202413:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202413:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202413:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202413:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202423:20EDGAR2Form 8-K - Current report
09/5/202417:29GLOBEPlus Therapeutics Provides Highlights Regarding..
08/5/202423:35GLOBEPlus Therapeutics to Host Investor Call to Discuss..
06/5/202413:30GLOBEPlus Therapeutics Announces Private Placement Financing of..
22/4/202413:00GLOBEPlus Therapeutics Receives $3 Million Award Recommendation..
08/3/202422:30EDGAR2Form S-1/A - General form for registration of securities..
05/3/202422:04EDGAR2Form 8-K - Current report
05/3/202422:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/2/202400:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202400:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202400:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202400:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202400:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202400:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202400:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202400:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202323:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202322:22EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
22/11/202322:08EDGAR2Form S-1 - General form for registration of securities under..
21/11/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
20/11/202313:01EDGAR2Form 8-K - Current report
17/11/202313:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202313:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202313:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202313:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202321:55EDGAR2Form 8-K - Current report
31/10/202321:06EDGAR2Form 8-K - Current report
31/10/202321:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/9/202313:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202313:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202313:00GLOBEPlus Therapeutics Receives $1.9 Million Advance Payment from..
08/9/202313:00GLOBEPlus Therapeutics Enters into License Agreement for..
05/9/202313:00GLOBEPlus Therapeutics Initiates Part B of ReSPECT-LM Phase 1/2a..
Apertura: 1,88 Min: 1,87 Max: 1,99
Chiusura: 1,93

La tua Cronologia

NASDAQ
PSTV
Plus Therapeutics
USOTC
EDNSF
Eden Research (QB)
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network